Cargando…

Intracerebroventricular dopamine for Parkinson's disease

Detalles Bibliográficos
Autores principales:	Devos, David, Devedjian, Jean-Christophe, Moreau, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542160/ https://www.ncbi.nlm.nih.gov/pubmed/28484085 http://dx.doi.org/10.18632/oncotarget.17596

Ejemplares similares

Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease
por: Duce, James A., et al.
Publicado: (2017)

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
por: Grolez, Guillaume, et al.
Publicado: (2015)

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
por: Hopes, Lucie, et al.
Publicado: (2016)

Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates
por: Gouel, Flore, et al.
Publicado: (2019)

Intracerebroventricular drug administration
por: Atkinson, Arthur J.
Publicado: (2017)

Intracerebroventricular transplanted bone marrow stem cells survive and migrate into the brain of rats with Parkinson's disease☆
por: Gu, Ping, et al.
Publicado: (2012)

Early occurrence of inspiratory muscle weakness in Parkinson’s disease
por: Baille, Guillaume, et al.
Publicado: (2018)

Homocysteine Intracerebroventricular Injection Induces Apoptosis in the Substantia Nigra Cells and Parkinson's Disease LikeBehavior in Rats
por: Ataie, Amin, et al.
Publicado: (2013)

Ventilatory Dysfunction in Parkinson’s Disease
por: Baille, Guillaume, et al.
Publicado: (2016)

NURS-01. INTRACEREBROVENTRICULAR DRUG ADMINISTRATION FOR TREATMENT OF PEDIATRIC BRAIN TUMORS
por: Fitzgerald, Caroline, et al.
Publicado: (2020)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Dopamine in Health and Disease
por: Ekker, Marc
Publicado: (2021)

Intracerebroventricular Injection of Metformin Induces Anorexia in Rats
por: Lee, Chang Koo, et al.
Publicado: (2012)

Neuroinflammation Induced by Intracerebroventricular Injection of Microbial Neuraminidase
por: Granados-Durán, Pablo, et al.
Publicado: (2015)

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
por: Biondetti, Emma, et al.
Publicado: (2021)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

An optimized intracerebroventricular injection of CD4(+) T cells into mice
por: Taylor, Zoe V., et al.
Publicado: (2021)

A method for intracerebroventricular cannulation of young broiler chicks
por: Lamberigts, Chris, et al.
Publicado: (2022)

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
por: da Conceição, Fabio S.L., et al.
Publicado: (2010)

Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease
por: Lhommée, Eugénie, et al.
Publicado: (2014)

Overview on wearable sensors for the management of Parkinson’s disease
por: Moreau, Caroline, et al.
Publicado: (2023)

In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin
por: Kraska, Audrey, et al.
Publicado: (2012)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

The effects of dopamine on digit span in Parkinson’s disease
por: Warden, Clara, et al.
Publicado: (2016)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020)

Texture-based markers from structural imaging correlate with motor handicap in Parkinson’s disease
por: Betrouni, Nacim, et al.
Publicado: (2021)

Effect of intraperitoneal or intracerebroventricular injection of streptozotocin on learning and memory in mice
por: Zhang, Yang, et al.
Publicado: (2018)

Low status, humiliation, dopamine and risk of schizophrenia
por: Selten, Jean Paul, et al.
Publicado: (2023)

Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism
por: Grieb, Paweł
Publicado: (2015)

Are Upper-Body Axial Symptoms a Feature of Early Parkinson’s Disease?
por: Moreau, Caroline, et al.
Publicado: (2016)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Intracerebroventricular Ghrelin Administration Increases Depressive-Like Behavior in Male Juvenile Rats
por: Jackson, Thomas M., et al.
Publicado: (2019)

Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation
por: van den Hoek, Anita M., et al.
Publicado: (2008)

Mitochondria and Parkinson's Disease
por: Simon, David K., et al.
Publicado: (2011)

The Influence of Dopamine on Automatic and Controlled Semantic Activation in Parkinson's Disease
por: Arnott, Wendy L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pkei0smcbashb63c0762lccr65